RAFAEL HOLDINGS INC-CLASS B (RFL) Stock Price, Forecast & Analysis
USA - NYSE:RFL - US75062E1064 - Common Stock
RFL Key Statistics, Chart & Performance
The current stock price of RFL is 1.22 USD. In the past month the price decreased by -7.58%. In the past year, price decreased by -33.33%.
RFL Latest News, Press Relases and Analysis
RFL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 46.62 | 970.39B | ||
| JNJ | JOHNSON & JOHNSON | 18.88 | 471.87B | ||
| MRK | MERCK & CO. INC. | 10.55 | 232.09B | ||
| PFE | PFIZER INC | 7.83 | 142.48B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.11 | 94.95B | ||
| ZTS | ZOETIS INC | 19.06 | 53.55B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.53 | 22.84B | ||
| VTRS | VIATRIS INC | 4.6 | 12.50B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.97 | 10.48B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.84 | 7.96B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 6.97B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 4.07B |
Related stock screener links
About RFL
Company Profile
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-03-12. The firm holds interests in clinical and early-stage pharmaceutical companies, including a 100% interest in Cyclo Therapeutics, LLC, a biotechnology company focusing on developing its lead clinical candidate, Trappsol Cyclo, which is being evaluated in clinical trials, including an ongoing Phase III trial for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal, and progressive genetic disorder. The company also holds an interest in LipoMedix Pharmaceuticals Ltd., a clinical-stage pharmaceutical company; Barer Institute Inc., a wholly owned preclinical cancer metabolism research operation, and an interest in Cornerstone Pharmaceuticals, Inc., a cancer metabolism-based therapeutics company. The company holds an interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and a majority interest in Day Three Labs, Inc.
Company Info
RAFAEL HOLDINGS INC-CLASS B
520 Broad Street
Newark NEW JERSEY 07102 US
CEO: Ameet Mallik
Employees: 30
Phone: 12126581450
RAFAEL HOLDINGS INC-CLASS B / RFL FAQ
What does RAFAEL HOLDINGS INC-CLASS B do?
Rafael Holdings, Inc. owns an interest in clinical and early-stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 28 full-time employees. The company went IPO on 2018-03-12. The firm holds interests in clinical and early-stage pharmaceutical companies, including a 100% interest in Cyclo Therapeutics, LLC, a biotechnology company focusing on developing its lead clinical candidate, Trappsol Cyclo, which is being evaluated in clinical trials, including an ongoing Phase III trial for the potential treatment of Niemann-Pick Disease Type C1 (NPC1), a rare, fatal, and progressive genetic disorder. The company also holds an interest in LipoMedix Pharmaceuticals Ltd., a clinical-stage pharmaceutical company; Barer Institute Inc., a wholly owned preclinical cancer metabolism research operation, and an interest in Cornerstone Pharmaceuticals, Inc., a cancer metabolism-based therapeutics company. The company holds an interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries, and a majority interest in Day Three Labs, Inc.
What is the current price of RFL stock?
The current stock price of RFL is 1.22 USD. The price decreased by -3.17% in the last trading session.
What is the dividend status of RAFAEL HOLDINGS INC-CLASS B?
RFL does not pay a dividend.
What is the ChartMill rating of RAFAEL HOLDINGS INC-CLASS B stock?
RFL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is RAFAEL HOLDINGS INC-CLASS B (RFL) stock traded?
RFL stock is listed on the New York Stock Exchange, Inc. exchange.
What is the market capitalization of RFL stock?
RAFAEL HOLDINGS INC-CLASS B (RFL) has a market capitalization of 42.81M USD. This makes RFL a Nano Cap stock.
RFL Technical Analysis
RFL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to RFL. The financial health of RFL is average, but there are quite some concerns on its profitability.
RFL Financial Highlights
Over the last trailing twelve months RFL reported a non-GAAP Earnings per Share(EPS) of -0.93. The EPS increased by 21.45% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.2% | ||
| ROE | -28.27% | ||
| Debt/Equity | 0.01 |